Quality assessment and Q-markers discovery of Tongsaimai tablet by integrating serum pharmacochemistry and network pharmacology for anti-atherosclerosis benefit

BACKGROUND: The limited therapeutic outcomes of atherosclerosis (AS) have allowed, traditional Chinese medicine has been well established as an alternative approach in ameliorating AS and associated clinical syndromes. Clinically, Tongsaimai tablet (TSMT), a commercial Chinese patent medicine approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yanfen, Xiao, Meng, Chen, Jiamei, Wang, Di, Hu, Yichen, Zhang, Chenfeng, Wang, Tuanjie, Fu, Chaomei, Wu, Yihan, Zhang, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438231/
https://www.ncbi.nlm.nih.gov/pubmed/36056398
http://dx.doi.org/10.1186/s13020-022-00658-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438231/
https://www.ncbi.nlm.nih.gov/pubmed/36056398
http://dx.doi.org/10.1186/s13020-022-00658-9

Ejemplares similares